We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+6.25%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$17.4B
AUM Growth
+$904M
Cap. Flow
+$84.9M
Cap. Flow %
0.49%
Top 10 Hldgs %
29.78%
Holding
722
New
36
Increased
329
Reduced
218
Closed
40

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$66.4M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$57.7M
3
AMZN icon
Amazon
AMZN
+$56.5M
4
AMD icon
Advanced Micro Devices
AMD
+$37.5M
5
CRM icon
Salesforce
CRM
+$35.5M

Top Sells

Rank Stock Value
1
LRCX icon
Lam Research
LRCX
+$122M
2
TMO icon
Thermo Fisher Scientific
TMO
+$60.8M
3
AMAT icon
Applied Materials
AMAT
+$43.7M
4
NU icon
Nu Holdings
NU
+$35.9M
5
INCY icon
Incyte
INCY
+$32.5M

Sector Composition

Rank Sector Weight
1 Technology 31.8%
2 Healthcare 28.54%
3 Financials 9.44%
4 Consumer Discretionary 7.84%
5 Industrials 7.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ETSY icon
651
Etsy
ETSY
$8.12B
– –
-7,367
Closed -$434K
EYPT icon
652
EyePoint Inc
EYPT
$999M
– –
-383,000
Closed -$3.33M
GATX icon
653
GATX Corp
GATX
$6.45B
– –
-1,938
Closed -$569K
HQY icon
654
HealthEquity
HQY
$8.71B
– –
-2,784
Closed -$240K
HTHT icon
655
Huazhu Hotels Group
HTHT
$13.3B
– –
-18,500
Closed -$616K
JBL icon
656
Jabil
JBL
$30.1B
– –
-65,684
Closed -$7.15M
KFY icon
657
Korn Ferry
KFY
$4.31B
– –
-23,176
Closed -$1.56M
KIM icon
658
Kimco Realty
KIM
$17.5B
– –
-324,421
Closed -$6.31M
KRC icon
659
Kilroy Realty
KRC
$4.59B
– –
-87,594
Closed -$2.73M
LRCX icon
660
Lam Research
LRCX
$316B
– –
-1,145,150
Closed -$122M
LW icon
661
Lamb Weston
LW
$7.42B
– –
-257,953
Closed -$21.7M
MNSO icon
662
MINISO
MNSO
$3.88B
– –
-30,500
Closed -$7.67M
MTG icon
663
MGIC Investment
MTG
$6.47B
– –
-188,205
Closed -$4.06M
MTN icon
664
Vail Resorts
MTN
$5.7B
– –
-1,969
Closed -$355K
RHI icon
665
Robert Half
RHI
$4.11B
– –
-15,085
Closed -$965K
RL icon
666
Ralph Lauren
RL
$22.4B
– –
-45,262
Closed -$7.92M
RTX icon
667
RTX Corp
RTX
$290B
– –
-3,265
Closed -$328K
SEDG icon
668
SolarEdge
SEDG
$2.37B
– –
-32,052
Closed -$810K
SHLS icon
669
Shoals Technologies Group
SHLS
$1.33B
– –
-381,988
Closed -$2.38M
SLG icon
670
SL Green Realty
SLG
$3.83B
– –
-137,533
Closed -$7.79M
SMCI icon
671
Super Micro Computer
SMCI
$16.6B
– –
-30,090
Closed -$2.47M
TNET icon
672
TriNet
TNET
$3.23B
– –
-60,353
Closed -$6.04M
VIPS icon
673
Vipshop
VIPS
$7.26B
– –
-28,000
Closed -$8.05M
VITL icon
674
Vital Farms
VITL
$586M
– –
-6,146
Closed -$287K
XNCR icon
675
Xencor
XNCR
$1.45B
– –
-310,019
Closed -$5.87M
24 25 26
27
28

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q3 2024 Portfolio in Review

As of Q3 2024, Candriam SCA held 722 positions worth $17.4B, up 5.5% from $16.5B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Candriam SCA's Q3 2024 filing shows 36 new, 329 increased, 218 reduced and 40 closed positions. Its largest new stake was Avidity Biosciences: 323,396 shares worth $14.9M. The largest sale was Lam Research, an estimated $122M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 33% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q3 2024 buy was Avidity Biosciences: 323,396 shares worth $14.9M.
  • Candriam SCA added most to Amgen in Q3 2024, an estimated $66.4M increase.
  • Candriam SCA's biggest Q3 2024 reduction was Thermo Fisher Scientific, cutting an estimated $60.8M.
  • Candriam SCA fully exited Lam Research in Q3 2024, selling an estimated $122M.
  • Candriam SCA's ten largest holdings make up 30% of its $17.4B portfolio in Q3 2024.
  • Candriam SCA opened 36 new positions and closed 40 in Q3 2024.
  • Candriam SCA's portfolio value rose 5.5% quarter-over-quarter to $17.4B.

Based on Candriam SCA's 13F filing for Q3 2024, filed 13 Nov 2024.